IL-10 -592 C/A polymorphism association with hemorrhagic stroke/aneurysm and their risk factors
Associação do polimorfismo IL-10 -592 C/A com acidente vascular cerebral hemorrágico/aneurisma e seus fatores de risco
DOI:
https://doi.org/10.53660/CLM-3812-23P53Resumo
Stroke is one of the leading causes of death worldwide. Hemorrhagic strokes (HS) present higher mortality than ischemic stroke (IS) and promote disability and dependency on trivial activities in most patients. Although unclear for HS, inflammatory mediators appear to promote IS onset that anti-inflammatory cytokines, such as IL-10, could mitigate. Polymorphisms in cytokine locus can affect its expression, especially in regulation regions, or affect protein's structure and, consequently, its biological role, impacting its availability or performance and promoting pathogenesis. In this case-control study, we analyze IL-10 -592 C/A (rs1800872) polymorphism association with HS by investigating 162 participants - 81 patients with HS, aneurysm, or both and 81 healthy controls - from Federal District, Brazil. We also evaluate this polymorphism association with known risk factors for strokes - high blood pressure, smoking, alcoholism, and diabetes. Herein, we found no association between the IL-10 -592 C/A polymorphism and HS, nor the risk factors examined.
Downloads
Referências
AGNIHOTRI, Shruti et al. Peripheral leukocyte counts and outcomes after intracerebral hemorrhage. Journal of neuroinflammation, v. 8, p. 1-4, 2011. doi: 10.1186/1742-2094-8-160.
AIHARA, Yasuo et al. Quantitative analysis of gene expressions related to inflammation in canine spastic artery after subarachnoid hemorrhage. Stroke, v. 32, n. 1, p. 212-217, 2001. doi: 10.1161/01.STR.32.1.212.
ALBUQUERQUE, Felipe C. Hemorrhagic stroke: the broad horizon of aneurysm treatment. Journal of NeuroInterventional Surgery, v. 5, n. Suppl 3, p. iii1-iii2, 2013. doi: 10.1136/neurintsurg-2013-010935.
AMARENCO, Pierre et al. High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine, v. 355, n. 6, p. 549-559, 2006. doi: 10.1056/NEJMoa061894.
BANKS, Jamie L.; MAROTTA, Charles A. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke, v. 38, n. 3, p. 1091-1096, 2007. doi: 10.1161/01.STR.0000258355.23810.c6.
BONITA, Ruth et al. Passive smoking as well as active smoking increases the risk of acute stroke. Tobacco control, v. 8, n. 2, p. 156-160, 1999. doi: 10.1136/tc.8.2.156.
BORGES, Felipe SA et al. TNFA gene in Brazilian patients with hemorrhagic stroke or cerebral aneurysm. Jornal Brasileiro de Patologia e Medicina Laboratorial, v. 54, p. 164-169, 2018. doi: 10.5935/1676-2444.20180029.
CAMPBELL, Bruce CV; KHATRI, Pooja. Stroke. The Lancet, v. 396, n. 10244, p. 129–142, 2020. doi: 10.1016/S0140-6736(20)31179-X.
CEDERBERG, David; SIESJÖ, Peter. What has inflammation to do with traumatic brain injury?. Child's Nervous System, v. 26, p. 221-226, 2010. doi: 10.1007/s00381-009-1029-x.
CHAMORRO, Angel; URRA, Xabier; PLANAS, Anna M. Infection after acute ischemic stroke: a manifestation of brain-induced immunodepression. Stroke, v. 38, n. 3, p. 1097-1103, 2007. doi: 10.1161/01.STR.0000258346.68966.9d.
CHAPMAN, Katie Z. et al. A rapid and transient peripheral inflammatory response precedes brain inflammation after experimental stroke. Journal of Cerebral Blood Flow & Metabolism, v. 29, n. 11, p. 1764-1768, 2009. doi: 10.1038/jcbfm.2009.113.
CHEN, Miao; YANG, Yue. A meta-analysis on associations of IL-6 and IL-10 polymorphisms with susceptibility to ischemic stroke. Journal of neuroimmunology, v. 335, p. 577004, 2019. doi: 10.1016/j.jneuroim.2019.577004.
DI NAPOLI, Mario et al. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke, v. 42, n. 5, p. 1230-1236, 2011. doi: 10.1161/STROKEAHA.110.604983.
ESKDALE, J. et al. Association between polymorphisms at the human IL‐10 locus and systemic lupus erythematosus. Tissue antigens, v. 49, n. 6, p. 635-639, 1997. doi: 10.1111/j.1399-0039.1997.tb02812.x.
FERRARESE, Carlo et al. Increased cytokine release from peripheral blood cells after acute stroke. Journal of Cerebral Blood Flow & Metabolism, v. 19, n. 9, p. 1004-1009, 1999. doi: 10.1097/00004647-199909000-00008.
FU, Ying et al. Immune interventions in stroke. Nature Reviews Neurology, v. 11, n. 9, p. 524-535, 2015. doi: 10.1038/nrneurol.2015.144.
GAKIDOU, Emmanuela et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, v. 390, n. 10100, p. 1345-1422, 2017. doi: 10.1016/S0140-6736(17)32366-8.
GAN, Yan et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proceedings of the National Academy of Sciences, v. 111, n. 7, p. 2704-2709, 2014. doi: 10.1073/pnas.1315943111.
GARCIA, Joshua M. et al. Role of interleukin-10 in acute brain injuries. Frontiers in neurology, v. 8, p. 244, 2017. doi: 10.3389/fneur.2017.00244.
GLOBAL BURDEN OF DISEASE STROKE EXPERT GROUP et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. The New England Journal of Medicine, v. 379, n. 25, p. 2429-2437, 2018. doi: 10.1056/NEJMoa1804492.
HART, Robert G.; PEARCE, Lesly A. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation. Annals of Internal Medicine, v. 132, n. 10, p. 841-842, 2000. doi: 10.7326/0003-4819-131-7-199910050-00003.
HATANO, S. Variability of the diagnosis of stroke by clinical judgement and by a scoring method. Bulletin of the World Health Organization, v. 54, n. 5, p. 533, 1976.
HAY, Simon I. et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, v. 390, n. 10100, p. 1260-1344, 2017. doi: 10.1016/S0140-6736(17)32130-X.
IADECOLA, Costantino; ANRATHER, Josef. The immunology of stroke: from mechanisms to translation. Nature medicine, v. 17, n. 7, p. 796-808, 2011. doi: 10.1038/nm.2399.
KES, Vanja Basic et al. Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome. Clinical Biochemistry, v. 41, n. 16-17, p. 1330-1334, 2008. doi: 10.1016/j.clinbiochem.2008.08.080.
KOOIJMAN, Elke et al. The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies. Journal of neuroinflammation, v. 11, p. 1-12, 2014. doi: 10.1186/1742-2094-11-2.
KRUPINSKI, Jerzy et al. Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke, v. 27, n. 5, p. 852-857, 1996. doi: 10.1161/01.STR.27.5.852.
LAWES, Carlene MM et al. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes care, v. 27, n. 12, p. 2836-2842, 2004. doi: 10.2337/diacare.27.12.2836.
LAWES, Carlene MM et al. Blood pressure and stroke: an overview of published reviews. Stroke, v. 35, n. 3, p. 776-785, 2004. doi: 10.1161/01.STR.0000116869.64771.5A.
LAZARUS, Mark et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. The Journal of rheumatology, v. 24, n. 12, p. 2314-2317, 1997.
LLORENTE, Luis et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. The Journal of experimental medicine, v. 181, n. 3, p. 839-844, 1995. doi: 10.1084/jem.181.3.839.
LLORENTE, Luis et al. Dysregulation of interleukin‐10 production in relatives of patients with systemic lupus erythematosus. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, v. 40, n. 8, p. 1429-1435, 1997. doi: 10.1002/art.1780400810.
MOSKOWITZ, Michael A.; LO, Eng H.; IADECOLA, Costantino. The science of stroke: mechanisms in search of treatments. Neuron, v. 67, n. 2, p. 181-198, 2010. doi: 10.1016/j.neuron.2010.07.002.
MRACSKO, Eva; VELTKAMP, Roland. Neuroinflammation after intracerebral hemorrhage. Frontiers in cellular neuroscience, v. 8, p. 388, 2014. doi: 10.3389/fncel.2014.00388.
NAGHAVI, Mohsen et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The lancet, v. 390, n. 10100, p. 1151-1210, 2017. doi: 10.1016/S0140-6736(17)32152-9.
OFFNER, Halina et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. Journal of Cerebral Blood Flow & Metabolism, v. 26, n. 5, p. 654-665, 2006. doi: 10.1038/sj.jcbfm.9600217.
OUYANG, Wenjun; O’GARRA, Anne. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity, v. 50, n. 4, p. 871-891, 2019. doi: 10.1016/j.immuni.2019.03.020.
PATTERSON, Zachary R.; HOLAHAN, Matthew R. Understanding the neuroinflammatory response following concussion to develop treatment strategies. Frontiers in cellular neuroscience, v. 6, p. 58, 2012. doi: 10.3389/fncel.2012.00058.
PRASS, Konstantin et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1–like immunostimulation. The Journal of experimental medicine, v. 198, n. 5, p. 725-736, 2003. doi: 10.1084/jem.20021098.
RUI, Xiaodong et al. Serum level of IL-10 and IL-10-1082G/A polymorphism are associated with the risk of ischemic stroke: a meta-analysis. Journal of Biological Regulators and Homeostatic Agents, v. 34, n. 4, p. 1445-1449, 2020. doi: 10.23812/20-186-L.
SACCO, Ralph L. et al. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke, v. 44, n. 7, p. 2064-2089, 2013. doi: 10.1161/STR.0b013e318296aeca.
SATHYAN, Sanish et al. Pathogenesis of intracranial aneurysm is mediated by proinflammatory cytokine TNFA and IFNG and through stochastic regulation of IL10 and TGFB1 by comorbid factors. Journal of Neuroinflammation, v. 12, p. 1-10, 2015. doi: 10.1186/s12974-015-0354-0.
SIE, Mark PS et al. TGF-β1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam study. Stroke, v. 37, n. 11, p. 2667-2671, 2006. doi: 10.1161/01.STR.0000244779.30070.1a.
SONG, Si-Ying et al. Clinical significance of baseline neutrophil-to-lymphocyte ratio in patients with ischemic stroke or hemorrhagic stroke: an updated meta-analysis. Frontiers in neurology, v. 10, p. 1032, 2019. doi: 10.3389/fneur.2019.01032.
STARK, Konstantin; MASSBERG, Steffen. Interplay between inflammation and thrombosis in cardiovascular pathology. Nature Reviews Cardiology, v. 18, n. 9, p. 666-682, 2021. doi: 10.1038/s41569-021-00552-1.
TAJIRI, Naoki et al. Cerebral aneurysm as an exacerbating factor in stroke pathology and a therapeutic target for neuroprotection. Current Pharmaceutical Design, v. 18, n. 25, p. 3663-3669, 2012. doi: 10.2174/138161212802002724.
TURNER, DM et al. An investigation of polymorphism in the interleukin‐10 gene promoter. European journal of immunogenetics, v. 24, n. 1, p. 1-8, 1997. doi:10.1111/j.1365-2370.1997.tb00001.x.
VAN ASCH, Charlotte JJ et al. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. The Lancet Neurology, v. 9, n. 2, p. 167-176, 2010. doi: 10.1016/S1474-4422(09)70340-0.
WANG, Jian; DORÉ, Sylvain. Inflammation after intracerebral hemorrhage. Journal of Cerebral Blood Flow & Metabolism, v. 27, n. 5, p. 894-908, 2007. doi: 10.1038/sj.jcbfm.9600403.
ZUO, Shuang; ZHENG, Tingting; LI, Haishan. Association between interleukin-10-1082A/G polymorphism and risk of ischemic stroke: A meta-analysis. Medicine, v. 99, n. 5, p. e18858, 2020. doi: 10.1097/MD.0000000000018858.
ZUO, Shuang; ZHENG, Tingting; LI, Haishan. Association between interleukin-10-819T/C polymorphism and risk of ischemic stroke: A meta-analysis. Medicine, v. 99, n. 20, p. e198
